Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,807.20
-20.30 (-1.11%)
Nov 12, 2026, 3:29 PM IST

Aurobindo Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Market Capitalization
1,039,823757,598674,020637,941303,575391,729
Market Cap Growth
55.03%12.40%5.66%110.14%-22.50%-24.14%
Enterprise Value
1,026,322746,546689,676632,994283,996394,408
Last Close Price
1807.201304.401156.161084.68513.88653.35

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
26.1821.6219.3420.1115.7514.79
Forward PE
19.7718.0215.9117.7712.1912.83
PS Ratio
2.822.252.132.201.221.67
PB Ratio
2.642.002.072.141.131.59
P/TBV Ratio
3.122.312.362.461.311.85
P/FCF Ratio
32.7826.6734.45--13.22
P/OCF Ratio
17.5513.7117.1726.2012.727.81
PEG Ratio
0.931.441.360.781.632.09

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
2.782.222.172.181.141.68
EV/EBITDA Ratio
13.4911.0110.6310.987.819.15
EV/EBIT Ratio
17.9514.4913.6814.4111.3111.93
EV/FCF Ratio
32.3626.2835.25--13.31

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.220.210.250.220.200.12
Debt / EBITDA Ratio
1.131.181.261.141.430.65
Debt / FCF Ratio
2.722.844.22--0.96
Net Debt / Equity Ratio
-0.03-0.070.000.01-0.04-0.07
Net Debt / EBITDA Ratio
-0.18-0.370.010.06-0.26-0.40
Net Debt / FCF Ratio
-0.42-0.880.03-0.9355.51-0.58
Asset Turnover
0.650.620.670.680.670.69
Inventory Turnover
1.241.241.331.421.451.26
Quick Ratio
0.891.000.990.960.981.10
Current Ratio
1.731.811.851.981.882.22
Return on Equity (ROE)
10.71%9.93%11.15%11.18%7.50%11.39%
Return on Assets (ROA)
6.26%5.95%6.64%6.46%4.25%6.10%
Return on Invested Capital (ROIC)
10.66%10.37%11.03%11.33%7.60%11.66%
Return on Capital Employed (ROCE)
13.60%12.70%14.40%13.40%8.80%12.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
3.82%4.63%5.17%4.97%6.35%6.76%
FCF Yield
3.05%3.75%2.90%-0.54%-0.06%7.56%
Dividend Yield
0.39%0.31%-0.41%0.58%1.35%
Payout Ratio
0.01%6.63%0.03%8.31%22.80%9.96%
Buyback Yield / Dilution
0.47%0.36%0.52%---
Total Shareholder Return
0.86%0.66%0.52%0.41%0.58%1.35%